Review




Structured Review

MyeloRx Inc mrx102 antineoplastic drug
Mrx102 Antineoplastic Drug, supplied by MyeloRx Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/triptolide/mrx102+triptolide+derivative/pmc07982634-471-0-1
Average 90 stars, based on 1 article reviews
mrx102 antineoplastic drug - by Bioz Stars, 2026-11
90/100 stars

Images

Related Articles

Emulsion:

Article Title: Preclinical antileukemic activity, toxicology, toxicokinetics and formulation development of triptolide derivative MRx102
Article Snippet: .. We show here that, when administered i.v. in a preclinical rat toxicology study using a novel emulsion formulation developed by MyeloRx, the new lipophilic triptolide prodrug derivative, MRx102, displayed a 20− to 60-fold reduction in toxicity in direct comparison to triptolide, and MRx102 exhibited an improved toxicokinetic profile as well. ..

Formulation:

Article Title: Preclinical antileukemic activity, toxicology, toxicokinetics and formulation development of triptolide derivative MRx102
Article Snippet: .. We show here that, when administered i.v. in a preclinical rat toxicology study using a novel emulsion formulation developed by MyeloRx, the new lipophilic triptolide prodrug derivative, MRx102, displayed a 20− to 60-fold reduction in toxicity in direct comparison to triptolide, and MRx102 exhibited an improved toxicokinetic profile as well. ..

Comparison:

Article Title: Preclinical antileukemic activity, toxicology, toxicokinetics and formulation development of triptolide derivative MRx102
Article Snippet: .. We show here that, when administered i.v. in a preclinical rat toxicology study using a novel emulsion formulation developed by MyeloRx, the new lipophilic triptolide prodrug derivative, MRx102, displayed a 20− to 60-fold reduction in toxicity in direct comparison to triptolide, and MRx102 exhibited an improved toxicokinetic profile as well. ..

other:

Article Title: Perspectives and controversies regarding the use of natural products for the treatment of lung cancer
Article Snippet: MRx102 (MyeloRx, Vallejo, CA) significantly reduces the activation of the cell proliferation, Wnt pathway, migration, and invasion of H460 and A549 cells.

Article Title: MRx102, a triptolide derivative, has potent antileukemic activity in vitro and in a murine model of AML
Article Snippet: Importantly, complete remissions were reported in a phase 1 study in patients with refractory or relapsing acute leukemias. ( 23 MRx102 is a potent triptolide derivative currently under development by MyeloRx.

Activity Assay:

Article Title: The triptolide derivative MRx102 inhibits Wnt pathway activation and has potent anti-tumor effects in lung cancer
Article Snippet: .. The triptolide derivative MRx102 (MyeloRx, Vallejo, CA) has been previously shown to have antileukemic activity both in vitro and in vivo by promoting apoptosis of AML cells and can overcome the protection garnered by the microenvironment [ ]. ..

In Vitro:

Article Title: The triptolide derivative MRx102 inhibits Wnt pathway activation and has potent anti-tumor effects in lung cancer
Article Snippet: .. The triptolide derivative MRx102 (MyeloRx, Vallejo, CA) has been previously shown to have antileukemic activity both in vitro and in vivo by promoting apoptosis of AML cells and can overcome the protection garnered by the microenvironment [ ]. ..

In Vivo:

Article Title: The triptolide derivative MRx102 inhibits Wnt pathway activation and has potent anti-tumor effects in lung cancer
Article Snippet: .. The triptolide derivative MRx102 (MyeloRx, Vallejo, CA) has been previously shown to have antileukemic activity both in vitro and in vivo by promoting apoptosis of AML cells and can overcome the protection garnered by the microenvironment [ ]. ..



Similar Products

99
Enamine Ltd triptolide
Triptolide, supplied by Enamine Ltd, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/triptolide/Triptolide/custom%40en300-19745751%4042515771
Average 99 stars, based on 1 article reviews
triptolide - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

95
MedChemExpress triptolide
(A) L1000CDS2 candidate screen highlighting 16-hydroxytriptolide. (B) Structures of <t>triptolide</t> and 16-hydroxytriptolide. (C,D) Representative triptolide docking pose and interface contacts in the S100A8 homodimer (PDB 5HLO). (E) Matched score differences between compounds across A/C and B/D receptors and Vina/Vinardo scoring. Scores from different functions are not directly comparable. (F) Contact-set Jaccard indices. (G) Complex and apo backbone RMSD across three 100-ns replicates. (H) Triptolide displacement from the original pocket, showing retention in replicate 2 and migration in replicates 1 and 3. Docking and dynamics do not establish direct binding.
Triptolide, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/triptolide/Triptolide/pmc13686462-141-0-1
Average 95 stars, based on 1 article reviews
triptolide - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

95
Selleck Chemicals rna poll initiation inhibitor triptolide
Micro Capture-C (MCC) analysis in MV4-11 cells upon Menin inhibition (VTP-50469, 500 nM, 3 days) and <t>RNA</t> Pol II initiation inhibition <t>(triptolide,</t> 500 nM, 1 h). ChIP-seq tracks for KMT2A and Menin are shown. Red boxes indicate captured regions (CpG island or AT-flank anchors). a, MCC analysis on the IGF2BP2 , CDK6 and MEIS1 loci. b, Micro Capture-C analysis on CDK6 and FOXP1 loci along with ATAC-seq and BRD4 ChIP-seq data to mark canonical enhancers. MENi, Menin inhibitor; TRP, triptolide.
Rna Poll Initiation Inhibitor Triptolide, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/triptolide/Triptolide/bio_rxiv__64898__2026__10__30__763078-223-0-8
Average 95 stars, based on 1 article reviews
rna poll initiation inhibitor triptolide - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

93
Tocris triptolide
Micro Capture-C (MCC) analysis in MV4-11 cells upon Menin inhibition (VTP-50469, 500 nM, 3 days) and <t>RNA</t> Pol II initiation inhibition <t>(triptolide,</t> 500 nM, 1 h). ChIP-seq tracks for KMT2A and Menin are shown. Red boxes indicate captured regions (CpG island or AT-flank anchors). a, MCC analysis on the IGF2BP2 , CDK6 and MEIS1 loci. b, Micro Capture-C analysis on CDK6 and FOXP1 loci along with ATAC-seq and BRD4 ChIP-seq data to mark canonical enhancers. MENi, Menin inhibitor; TRP, triptolide.
Triptolide, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/triptolide/Triptolide/10__1038_slash_s41467___026___77758___9-263-6-7
Average 93 stars, based on 1 article reviews
triptolide - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
Thermo Fisher triptolide
<t>Triptolide</t> promotes the clearance of intracellular SA and MRSA. (A) Schematic diagram of the procedure for screening TCM monomers that modulate intracellular SA clearance. (B) Representative results illustrating the effects of 15 TCM monomers that promoted intracellular SA clearance and 2 that inhibited it. DMSO and methicillin were used as the negative and positive controls, respectively. Intracellular survival analysis of SA (C) and MRSA (D) in iBMDMs treated with different concentrations of the designated TCM monomers. Data are shown as mean ± SEM [n = 3 in (B–D) ]. ***0.0001 ≤ P < 0.001; **** P < 0.0001 [one-way ANOVA with Dunnett’s post hoc test for (B–D) ].
Triptolide, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/triptolide/Triptolide/pmc13246675-94-17-40
Average 94 stars, based on 1 article reviews
triptolide - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

95
MedChemExpress 1000x stock concentration
<t>Triptolide</t> promotes the clearance of intracellular SA and MRSA. (A) Schematic diagram of the procedure for screening TCM monomers that modulate intracellular SA clearance. (B) Representative results illustrating the effects of 15 TCM monomers that promoted intracellular SA clearance and 2 that inhibited it. DMSO and methicillin were used as the negative and positive controls, respectively. Intracellular survival analysis of SA (C) and MRSA (D) in iBMDMs treated with different concentrations of the designated TCM monomers. Data are shown as mean ± SEM [n = 3 in (B–D) ]. ***0.0001 ≤ P < 0.001; **** P < 0.0001 [one-way ANOVA with Dunnett’s post hoc test for (B–D) ].
1000x Stock Concentration, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/triptolide/Triptolide/bio_rxiv__64898__2026__05__24__727549-348-3-9
Average 95 stars, based on 1 article reviews
1000x stock concentration - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

86
Baoji Titanium Industry Co Ltd triptolide
<t>Triptolide</t> promotes the clearance of intracellular SA and MRSA. (A) Schematic diagram of the procedure for screening TCM monomers that modulate intracellular SA clearance. (B) Representative results illustrating the effects of 15 TCM monomers that promoted intracellular SA clearance and 2 that inhibited it. DMSO and methicillin were used as the negative and positive controls, respectively. Intracellular survival analysis of SA (C) and MRSA (D) in iBMDMs treated with different concentrations of the designated TCM monomers. Data are shown as mean ± SEM [n = 3 in (B–D) ]. ***0.0001 ≤ P < 0.001; **** P < 0.0001 [one-way ANOVA with Dunnett’s post hoc test for (B–D) ].
Triptolide, supplied by Baoji Titanium Industry Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/triptolide/triptolide/10__2147_slash_ijn__s567165-48-0-7
Average 86 stars, based on 1 article reviews
triptolide - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results


(A) L1000CDS2 candidate screen highlighting 16-hydroxytriptolide. (B) Structures of triptolide and 16-hydroxytriptolide. (C,D) Representative triptolide docking pose and interface contacts in the S100A8 homodimer (PDB 5HLO). (E) Matched score differences between compounds across A/C and B/D receptors and Vina/Vinardo scoring. Scores from different functions are not directly comparable. (F) Contact-set Jaccard indices. (G) Complex and apo backbone RMSD across three 100-ns replicates. (H) Triptolide displacement from the original pocket, showing retention in replicate 2 and migration in replicates 1 and 3. Docking and dynamics do not establish direct binding.

Journal: PLOS One

Article Title: Multi-cohort transcriptomics and donor-aware single-cell analyses prioritize S100A8 within an emergency-myeloid, HLA-DR-low state in sepsis

doi: 10.1371/journal.pone.0359578

Figure Lengend Snippet: (A) L1000CDS2 candidate screen highlighting 16-hydroxytriptolide. (B) Structures of triptolide and 16-hydroxytriptolide. (C,D) Representative triptolide docking pose and interface contacts in the S100A8 homodimer (PDB 5HLO). (E) Matched score differences between compounds across A/C and B/D receptors and Vina/Vinardo scoring. Scores from different functions are not directly comparable. (F) Contact-set Jaccard indices. (G) Complex and apo backbone RMSD across three 100-ns replicates. (H) Triptolide displacement from the original pocket, showing retention in replicate 2 and migration in replicates 1 and 3. Docking and dynamics do not establish direct binding.

Article Snippet: Triptolide (MedChemExpress, HY-32735) was prepared as a DMSO stock and diluted immediately before use; all treatment groups had the same final DMSO concentration.

Techniques: Docking Assay, Migration, Binding Assay

(A) Eight-condition siNC/siS100A8×Control/TPL/LPS/LPS + TPL immunoblots. (B,C) p-NF-κB/total NF-κB and S100A8/β-actin across three independent experiments. (D) Four-condition siRNA × LPS immunoblots. (E-G) CD74/β-actin, HLA-DRα/β-actin, and S100A8/β-actin. (H) TPL effects under LPS and the dependency contrast. The p-NF-κB dependency contrast was −0.011 (95% CI −0.249 to 0.226; P = 0.857); the three-way interaction was P = 0.848.

Journal: PLOS One

Article Title: Multi-cohort transcriptomics and donor-aware single-cell analyses prioritize S100A8 within an emergency-myeloid, HLA-DR-low state in sepsis

doi: 10.1371/journal.pone.0359578

Figure Lengend Snippet: (A) Eight-condition siNC/siS100A8×Control/TPL/LPS/LPS + TPL immunoblots. (B,C) p-NF-κB/total NF-κB and S100A8/β-actin across three independent experiments. (D) Four-condition siRNA × LPS immunoblots. (E-G) CD74/β-actin, HLA-DRα/β-actin, and S100A8/β-actin. (H) TPL effects under LPS and the dependency contrast. The p-NF-κB dependency contrast was −0.011 (95% CI −0.249 to 0.226; P = 0.857); the three-way interaction was P = 0.848.

Article Snippet: Triptolide (MedChemExpress, HY-32735) was prepared as a DMSO stock and diluted immediately before use; all treatment groups had the same final DMSO concentration.

Techniques: Western Blot

Micro Capture-C (MCC) analysis in MV4-11 cells upon Menin inhibition (VTP-50469, 500 nM, 3 days) and RNA Pol II initiation inhibition (triptolide, 500 nM, 1 h). ChIP-seq tracks for KMT2A and Menin are shown. Red boxes indicate captured regions (CpG island or AT-flank anchors). a, MCC analysis on the IGF2BP2 , CDK6 and MEIS1 loci. b, Micro Capture-C analysis on CDK6 and FOXP1 loci along with ATAC-seq and BRD4 ChIP-seq data to mark canonical enhancers. MENi, Menin inhibitor; TRP, triptolide.

Journal: bioRxiv

Article Title: A Unique Promoter Architecture Defines Menin-KMT2A Complex Selectivity

doi: 10.64898/2026.10.30.763078

Figure Lengend Snippet: Micro Capture-C (MCC) analysis in MV4-11 cells upon Menin inhibition (VTP-50469, 500 nM, 3 days) and RNA Pol II initiation inhibition (triptolide, 500 nM, 1 h). ChIP-seq tracks for KMT2A and Menin are shown. Red boxes indicate captured regions (CpG island or AT-flank anchors). a, MCC analysis on the IGF2BP2 , CDK6 and MEIS1 loci. b, Micro Capture-C analysis on CDK6 and FOXP1 loci along with ATAC-seq and BRD4 ChIP-seq data to mark canonical enhancers. MENi, Menin inhibitor; TRP, triptolide.

Article Snippet: RNA Poll initiation inhibitor triptolide was obtained from Selleck.

Techniques: Capture-C, Analysis, Inhibition, ChIP-sequencing, ATAC-seq

Triptolide promotes the clearance of intracellular SA and MRSA. (A) Schematic diagram of the procedure for screening TCM monomers that modulate intracellular SA clearance. (B) Representative results illustrating the effects of 15 TCM monomers that promoted intracellular SA clearance and 2 that inhibited it. DMSO and methicillin were used as the negative and positive controls, respectively. Intracellular survival analysis of SA (C) and MRSA (D) in iBMDMs treated with different concentrations of the designated TCM monomers. Data are shown as mean ± SEM [n = 3 in (B–D) ]. ***0.0001 ≤ P < 0.001; **** P < 0.0001 [one-way ANOVA with Dunnett’s post hoc test for (B–D) ].

Journal: Frontiers in Pharmacology

Article Title: Triptolide clears Staphylococcus aureus infection by targeting XIAP to induce host apoptosis while maintaining gut microbiota homeostasis

doi: 10.3389/fphar.2026.1834558

Figure Lengend Snippet: Triptolide promotes the clearance of intracellular SA and MRSA. (A) Schematic diagram of the procedure for screening TCM monomers that modulate intracellular SA clearance. (B) Representative results illustrating the effects of 15 TCM monomers that promoted intracellular SA clearance and 2 that inhibited it. DMSO and methicillin were used as the negative and positive controls, respectively. Intracellular survival analysis of SA (C) and MRSA (D) in iBMDMs treated with different concentrations of the designated TCM monomers. Data are shown as mean ± SEM [n = 3 in (B–D) ]. ***0.0001 ≤ P < 0.001; **** P < 0.0001 [one-way ANOVA with Dunnett’s post hoc test for (B–D) ].

Article Snippet: For transcriptomics analysis, total RNA was extracted from iBMDMs infected with SA and treated with DMSO or triptolide, and from lung macrophages of mice infected with SA or MRSA treated with PBS, triptolide, or methicillin according to the TRIzol® manual (Life Technologies, 15596-026).

Techniques:

Triptolide triggers activation of the apoptotic signaling pathway. Gene Ontology (GO) enrichment analysis of differentially expressed genes (A) and proteins (B) in SA-infected iBMDMs treated with triptolide versus DMSO. Volcano maps depicting differentially expressed genes (C) and proteins (D) in SA-infected iBMDMs treated with triptolide versus DMSO. (E) Representative results of fluorescence-activated cell sorting (FACS)-based analysis for percentages of apoptotic cells. Quantification of apoptosis in SA (F) - and MRSA (G) -infected cells treated with DMSO, triptolide, or methicillin. Immunoblotting analysis of cleaved caspase-3 in SA (H) - and MRSA (I) -infected cells treated with DMSO, triptolide, or methicillin. Q-VD-OPh was used as the caspase inhibitor. Data are shown as mean ± SEM [n = 4 in (F,G) ]. **** P < 0.0001 [two-way ANOVA with Tukey’s post-hoc test for (F,G) ].

Journal: Frontiers in Pharmacology

Article Title: Triptolide clears Staphylococcus aureus infection by targeting XIAP to induce host apoptosis while maintaining gut microbiota homeostasis

doi: 10.3389/fphar.2026.1834558

Figure Lengend Snippet: Triptolide triggers activation of the apoptotic signaling pathway. Gene Ontology (GO) enrichment analysis of differentially expressed genes (A) and proteins (B) in SA-infected iBMDMs treated with triptolide versus DMSO. Volcano maps depicting differentially expressed genes (C) and proteins (D) in SA-infected iBMDMs treated with triptolide versus DMSO. (E) Representative results of fluorescence-activated cell sorting (FACS)-based analysis for percentages of apoptotic cells. Quantification of apoptosis in SA (F) - and MRSA (G) -infected cells treated with DMSO, triptolide, or methicillin. Immunoblotting analysis of cleaved caspase-3 in SA (H) - and MRSA (I) -infected cells treated with DMSO, triptolide, or methicillin. Q-VD-OPh was used as the caspase inhibitor. Data are shown as mean ± SEM [n = 4 in (F,G) ]. **** P < 0.0001 [two-way ANOVA with Tukey’s post-hoc test for (F,G) ].

Article Snippet: For transcriptomics analysis, total RNA was extracted from iBMDMs infected with SA and treated with DMSO or triptolide, and from lung macrophages of mice infected with SA or MRSA treated with PBS, triptolide, or methicillin according to the TRIzol® manual (Life Technologies, 15596-026).

Techniques: Activation Assay, Infection, Fluorescence, FACS, Western Blot

Triptolide induces apoptosis through targeting XIAP. (A) Measurement of triptolide binding affinity to Bcl2, STAT1, and XIAP by octet. (B) Molecular docking analysis between triptolide and XIAP. The BIR2 and BIR3 domains of XIAP are shown in orange. RMSD (C) and Rg (D) curves depicting the interaction between triptolide and XIAP. RMSD, root mean square deviation; Rg, radius of gyration. (E) Blocking assay to assess the effect of triptolide or SM-164 on XIAP-caspase-3/9 interaction. Quantification of apoptosis in SA (F) - and MRSA (G) -infected cells treated with DMSO, triptolide, SM-164, triptolide in combination with SM-164, or methicillin. Data are shown as mean ± SEM [n = 3 in (F,G) ]. **0.001 ≤ P < 0.01; ***0.0001 ≤ P < 0.001; **** P < 0.0001 [one-way ANOVA with Dunnett’s post hoc test for (F,G) ].

Journal: Frontiers in Pharmacology

Article Title: Triptolide clears Staphylococcus aureus infection by targeting XIAP to induce host apoptosis while maintaining gut microbiota homeostasis

doi: 10.3389/fphar.2026.1834558

Figure Lengend Snippet: Triptolide induces apoptosis through targeting XIAP. (A) Measurement of triptolide binding affinity to Bcl2, STAT1, and XIAP by octet. (B) Molecular docking analysis between triptolide and XIAP. The BIR2 and BIR3 domains of XIAP are shown in orange. RMSD (C) and Rg (D) curves depicting the interaction between triptolide and XIAP. RMSD, root mean square deviation; Rg, radius of gyration. (E) Blocking assay to assess the effect of triptolide or SM-164 on XIAP-caspase-3/9 interaction. Quantification of apoptosis in SA (F) - and MRSA (G) -infected cells treated with DMSO, triptolide, SM-164, triptolide in combination with SM-164, or methicillin. Data are shown as mean ± SEM [n = 3 in (F,G) ]. **0.001 ≤ P < 0.01; ***0.0001 ≤ P < 0.001; **** P < 0.0001 [one-way ANOVA with Dunnett’s post hoc test for (F,G) ].

Article Snippet: For transcriptomics analysis, total RNA was extracted from iBMDMs infected with SA and treated with DMSO or triptolide, and from lung macrophages of mice infected with SA or MRSA treated with PBS, triptolide, or methicillin according to the TRIzol® manual (Life Technologies, 15596-026).

Techniques: Binding Assay, Blocking Assay, Infection

Triptolide reduces SA and MRSA survival and attenuates host inflammatory pathology in vivo (A) Diagram of the experimental design in mice. Bacterial loads of SA (B) and MRSA (C) in the lungs of C57BL/6N mice treated with PBS, triptolide, or methicillin. (D) Representative images and quantitation for inflammatory areas in the lungs of C57BL/6N mice treated as in (B,C) . Scale bar, 100 μm. (E) Immunofluorescence and quantitation for cleaved caspase-3 (red) in the lung macrophages (green) of C57BL/6N mice treated as in (B,C) . Scale bar, 20 μm. Data are shown as mean ± SEM [n = 4 in (B–E) ]. *0.01 ≤ P < 0.5; **0.001 ≤ P < 0.01; ***0.0001 ≤ P < 0.001; **** P < 0.0001 [one-way ANOVA with Tukey’s post-hoc test for (B–E) ].

Journal: Frontiers in Pharmacology

Article Title: Triptolide clears Staphylococcus aureus infection by targeting XIAP to induce host apoptosis while maintaining gut microbiota homeostasis

doi: 10.3389/fphar.2026.1834558

Figure Lengend Snippet: Triptolide reduces SA and MRSA survival and attenuates host inflammatory pathology in vivo (A) Diagram of the experimental design in mice. Bacterial loads of SA (B) and MRSA (C) in the lungs of C57BL/6N mice treated with PBS, triptolide, or methicillin. (D) Representative images and quantitation for inflammatory areas in the lungs of C57BL/6N mice treated as in (B,C) . Scale bar, 100 μm. (E) Immunofluorescence and quantitation for cleaved caspase-3 (red) in the lung macrophages (green) of C57BL/6N mice treated as in (B,C) . Scale bar, 20 μm. Data are shown as mean ± SEM [n = 4 in (B–E) ]. *0.01 ≤ P < 0.5; **0.001 ≤ P < 0.01; ***0.0001 ≤ P < 0.001; **** P < 0.0001 [one-way ANOVA with Tukey’s post-hoc test for (B–E) ].

Article Snippet: For transcriptomics analysis, total RNA was extracted from iBMDMs infected with SA and treated with DMSO or triptolide, and from lung macrophages of mice infected with SA or MRSA treated with PBS, triptolide, or methicillin according to the TRIzol® manual (Life Technologies, 15596-026).

Techniques: In Vivo, Quantitation Assay, Immunofluorescence

Transcriptomics and proteomics analysis revealing that triptolide induces apoptosis in lung macrophages from mice infected with SA or MRSA. (A) GO enrichment analysis of differentially expressed genes in SA-infected mice treated with PBS, triptolide, or methicillin. (B) GO enrichment analysis of differentially expressed genes in MRSA-infected mice treated with PBS, triptolide, or methicillin. (C) GO enrichment analysis of differentially expressed proteins in mice treated as in (A) . (D) GO enrichment analysis of differentially expressed proteins in mice treated as in (B) .

Journal: Frontiers in Pharmacology

Article Title: Triptolide clears Staphylococcus aureus infection by targeting XIAP to induce host apoptosis while maintaining gut microbiota homeostasis

doi: 10.3389/fphar.2026.1834558

Figure Lengend Snippet: Transcriptomics and proteomics analysis revealing that triptolide induces apoptosis in lung macrophages from mice infected with SA or MRSA. (A) GO enrichment analysis of differentially expressed genes in SA-infected mice treated with PBS, triptolide, or methicillin. (B) GO enrichment analysis of differentially expressed genes in MRSA-infected mice treated with PBS, triptolide, or methicillin. (C) GO enrichment analysis of differentially expressed proteins in mice treated as in (A) . (D) GO enrichment analysis of differentially expressed proteins in mice treated as in (B) .

Article Snippet: For transcriptomics analysis, total RNA was extracted from iBMDMs infected with SA and treated with DMSO or triptolide, and from lung macrophages of mice infected with SA or MRSA treated with PBS, triptolide, or methicillin according to the TRIzol® manual (Life Technologies, 15596-026).

Techniques: Transcriptomics, Infection

Metagenomics analysis revealing that triptolide maintains microbiota homeostasis in mice infected with SA or MRSA. (A) Alpha (α) diversity among SA-infected mice treated with PBS, triptolide, or methicillin. (B) Alpha (α) diversity among MRSA-infected mice treated with PBS, triptolide, or methicillin. (C) Differential analysis of gut microbial composition among SA-infected mice treated as in (A) . (D) Differential analysis of gut microbial composition among MRSA-infected mice treated as in (B) .

Journal: Frontiers in Pharmacology

Article Title: Triptolide clears Staphylococcus aureus infection by targeting XIAP to induce host apoptosis while maintaining gut microbiota homeostasis

doi: 10.3389/fphar.2026.1834558

Figure Lengend Snippet: Metagenomics analysis revealing that triptolide maintains microbiota homeostasis in mice infected with SA or MRSA. (A) Alpha (α) diversity among SA-infected mice treated with PBS, triptolide, or methicillin. (B) Alpha (α) diversity among MRSA-infected mice treated with PBS, triptolide, or methicillin. (C) Differential analysis of gut microbial composition among SA-infected mice treated as in (A) . (D) Differential analysis of gut microbial composition among MRSA-infected mice treated as in (B) .

Article Snippet: For transcriptomics analysis, total RNA was extracted from iBMDMs infected with SA and treated with DMSO or triptolide, and from lung macrophages of mice infected with SA or MRSA treated with PBS, triptolide, or methicillin according to the TRIzol® manual (Life Technologies, 15596-026).

Techniques: Metagenomics, Infection

Metabolomics analysis revealing that triptolide enhances immunomodulatory metabolites against infections. (A) Partial least-squares discriminant analysis (PLS-DA) score plots of metabolites from SA-infected mice treated with PBS, triptolide, or methicillin. (B) PLS-DA score plots of metabolites from MRSA-infected mice treated with PBS, triptolide, or methicillin. (C) Heatmap of differential metabolites among SA-infected mice treated as in (A) . (D) Heatmap of differential metabolites among MRSA-infected mice treated as in (B) .

Journal: Frontiers in Pharmacology

Article Title: Triptolide clears Staphylococcus aureus infection by targeting XIAP to induce host apoptosis while maintaining gut microbiota homeostasis

doi: 10.3389/fphar.2026.1834558

Figure Lengend Snippet: Metabolomics analysis revealing that triptolide enhances immunomodulatory metabolites against infections. (A) Partial least-squares discriminant analysis (PLS-DA) score plots of metabolites from SA-infected mice treated with PBS, triptolide, or methicillin. (B) PLS-DA score plots of metabolites from MRSA-infected mice treated with PBS, triptolide, or methicillin. (C) Heatmap of differential metabolites among SA-infected mice treated as in (A) . (D) Heatmap of differential metabolites among MRSA-infected mice treated as in (B) .

Article Snippet: For transcriptomics analysis, total RNA was extracted from iBMDMs infected with SA and treated with DMSO or triptolide, and from lung macrophages of mice infected with SA or MRSA treated with PBS, triptolide, or methicillin according to the TRIzol® manual (Life Technologies, 15596-026).

Techniques: Infection